Care of patients with systemic immunoglobulin light chain (AL) amyloidosis has undergone transformative changes, leading to marked, steady progress in outcomes for patients over the past four decades.

It’s commonly thought that excessive build-up of amyloid plaques, destroying the connections between nerve cells, is the first sign of Alzheimer’s disease. Now however, a new study challenges this ...

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...

Explore the potential of experimental drug NU-9 in early Alzheimer's intervention, targeting toxic amyloid beta forms.

Amyloidosis is a rare disease that involves the buildup of a specific protein called amyloid. Unlike other proteins, amyloid does not have a supportive role in the body. Instead, the buildup of ...

While many changes have been observed in the brains of Alzheimer's disease patients, amyloid plaques are considered a hallmark of the disease. Though beta-amyloid has not been shown conclusively to be ...

The bar for quality in cardiac amyloid radionuclide imaging is very high because the results from a single imaging scan can impact the diagnosis and treatment of patients with a devastating disease.” ...

Healio spoke with Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, about the process of diagnosing amyloidosis, the importance of multidisciplinary care in patients ...

Amyloid heart disease occurs when amyloid fibrils build up in the heart, making it more difficult for the heart to pump blood around the body. Eventually, this can lead to heart failure. People can ...